-

Susan G. Komen® To Host 2025 Race for the Cure in Detroit This September

Community Event to Support People with Breast Cancer, Raise Funds for Research and Advocacy Takes Place September 13, 2025

DETROIT--(BUSINESS WIRE)--Susan G. Komen®, the world’s leading breast cancer organization, will convene breast cancer survivors, those living with metastatic breast cancer (MBC) and supporters at the 2025 Susan G. Komen Detroit Race for the Cure. This impactful event unites our community and raises money for the mission of Komen, supporting those affected by breast cancer.

This event generates critical funds that allow Komen to continue its investment in lifesaving work across the country, including promising research that will allow people to live longer lives with better outcomes.

Share

Komen aims to raise over $300,000 at the Detroit Race for the Cure, generating critical funds that allow Komen to continue its investment in lifesaving work across the country, including promising research that will allow people to live longer lives with better outcomes. This event also funds Komen’s Patient Care Center, a trusted, go-to source for timely, accurate breast health and breast cancer information, support and resources, as well as the work of Komen’s Center for Public Policy to drive state and federal policies that invest in critical programs and ensure streamlined access to affordable, high-quality breast health care.

WHEN: Saturday, September 13, 2025

WHERE: William G. Milliken State Park - 1900 Atwater St, Detroit, MI 48207

REGISTER: www.komen.org/detroitrace

DETAILS: 7:00 a.m. Site Opens – 9:00 a.m. Opening Ceremony

WHY IT MATTERS: Breast cancer affects 1 in 8 women in the U.S. and 1 in 1,000 men in their lifetime. In 2025 alone, an estimated 316,950 women in the U.S. will be diagnosed with breast cancer and 42,170 women will die from the disease. Approximately 2,800 men will be diagnosed with breast cancer and 510 will die from it. However, some experts say one-third of breast cancer deaths in the U.S. could be prevented with universal access to modern treatments.

In Michigan, approximately over 66,000 people will be diagnosed with breast cancer and over 21,500 will die from the disease this year. Susan G. Komen provides direct support to Michiganians through its Patient Care Center. In fiscal year 2025, Komen provided assistance to over 640 patients, including over $178,000 in financial assistance to eligible people in active treatment or living with metastatic breast cancer.

“The work Komen does for people with breast cancer, survivors and those with increased risk of breast cancer is not possible without the Detroit Race for the Cure and the critical money we raise from our generous supporters,” said Gretchen Awad, executive director Northwest Ohio & Detroit at Susan G. Komen. “We look forward to bringing together the Detroit community this fall and uniting around our goal of creating a world where we do not lose another life to this disease.”

This year’s Komen Detroit Race for the Cure is made possible by the following sponsors: Ford Warriors in Pink, WDIV, Merck, Meijer, GAA Manufacturing, McDonald Hopkins, Oswald, Marathon, Kelly Services, Diagnostic Green, Harlan Electric, Joyology, Auto Owners Insurance, Fresh Thyme, Collingwood Water, Starbucks, Playa Bowls, Paul Mitchell The School Michigan.

Bank of America is the national presenting sponsor and Lilly, Natera, and Novartis are national series sponsors for the MORE THAN PINK Walk and Race for the Cure events.

About Susan G. Komen®

Susan G. Komen® is the world’s leading nonprofit breast cancer organization, working to save lives and end breast cancer forever. Komen has an unmatched, comprehensive 360-degree approach to fighting this disease across all fronts and supporting millions of people in the U.S. and in countries worldwide. We advocate for patients, drive research breakthroughs, improve access to high-quality care, offer direct patient support and empower people with trustworthy information. Founded by Nancy G. Brinker, who promised her sister, Susan G. Komen, that she would end the disease that claimed Suzy’s life, Komen remains committed to supporting those affected by breast cancer today, while tirelessly searching for tomorrow’s cures. Visit komen.org or call 1-877 GO KOMEN. Connect with us on social at www.komen.org/contact-us/follow-us/.

Contacts

Cris Martinez
Susan G. Komen
Phone (972) 701-2135
Email: cmartinez@komen.org

Susan G. Komen


Release Versions

Contacts

Cris Martinez
Susan G. Komen
Phone (972) 701-2135
Email: cmartinez@komen.org

More News From Susan G. Komen

Susan G. Komen® Announces Major Step Toward Greater Recognition of Inflammatory Breast Cancer

DALLAS--(BUSINESS WIRE)--Susan G. Komen®, the world’s leading breast cancer organization, announced a major step forward in its work to detect, treat and better understand the prevalence of Inflammatory Breast Cancer (IBC). As a result of Komen’s commitment to conquering aggressive and deadly cancers, and its longstanding support of the IBC community, Komen and its collaboration partners have secured three new ICD-10-CM (International Classification of Disease, Tenth Revision, Clinical Modifica...

Lives on the Line: Komen® Speaks Out Against Reconciliation Bill as Millions Stand to Lose Coverage

DALLAS--(BUSINESS WIRE)--Susan G. Komen®, the world’s leading nonprofit breast cancer organization, is deeply troubled by passage of the One Big Beautiful Bill Act which implements damaging reforms to federal health insurance programs. The Congressional Budget Office estimates these changes, combined with the failure to renew health care tax credits, could cause nearly 17 million people to lose their insurance coverage, increasing the U.S. uninsured rate by 30%. As a direct result of the action...

Susan G. Komen® Applauds U.S. Supreme Court Decision Protecting No-cost Access to Lifesaving Breast Care

WASHINGTON--(BUSINESS WIRE)--Susan G. Komen®, the world’s leading breast cancer organization, commends the United States Supreme Court’s decision to overturn a lower court decision that threatened access to preventive breast care services, including screening mammography, risk-reducing medications for high-risk individuals, and genetic counseling and testing for some with a personal or family history of breast or related cancers. The ruling in Braidwood Management, Inc., et al v. Robert Kennedy...
Back to Newsroom